Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

1.7K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

788
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same author

[S1 guideline on sustainability in intensive care and emergency medicine].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2025
Same author

[Intensive care and emergency medicine overuse and sustainability].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2024
Same author

[Summary of the S1 guideline on sustainability in intensive care and emergency medicine].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2024
Same author

Diagnostics and Therapy of Venous Thrombosis and Pulmonary Embolism. The revised AWMF S2k Guideline

VASA. Zeitschrift fur Gefasskrankheiten·2023
Same author

[Current ethical aspects in intensive care medicine].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2021
Same journal

[Modern therapy of pulmonary embolism with PERT and EKOS: an advantage also for in-hospital time?]

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[Extracorporeal immunomodulation in sepsis : Role, limits, and perspectives of adjuvant blood purification therapies].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[Invasive mechanical ventilation: indications and alternatives : Systematic evaluation of the evidence and recommendations for clinical practice from the S3 guidelines "invasive mechanical ventilation and the use of extracorporeal procedures in acute respiratory failure"].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[Out-of-hospital cardiac arrest : Current recommendations along the chain of survival and patient management].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[Videolaryngoscopic endotracheal intubation during out-of-hospital cardiac arrest from the perspective of paramedics : Training requirements and subjective procedural confidence-results of an anonymous cross-sectional survey].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same journal

[The Freiburg concept of the "Neurological Emergency Receiving Team (NERT)" : Concept for structuring of time-critical courses of action for patients with a predominant disability problem with an interdisciplinary and interprofessional emergency team in the nontraumatological resuscitation room].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

12.6K

[Dying with/despite a pacemaker].

S Reith1, U Janssens

  • 1Medizinische Klinik I, Universitätsklinikum Aachen, Aachen, Deutschland.

Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|January 4, 2014
PubMed
Summary
This summary is machine-generated.

Intensive care unit (ICU) physicians must understand the ethical and legal issues surrounding cardiovascular implantable electronic device (CIED) deactivation in dying patients. Patient consent is essential for deactivating devices like pacemakers and implantable cardioverter-defibrillators (ICDs).

More Related Videos

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

3.0K
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

27.5K

Related Experiment Videos

Last Updated: May 4, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

12.6K
Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

3.0K
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

27.5K

Area of Science:

  • Cardiology
  • Medical Ethics
  • Intensive Care Medicine

Context:

  • Cardiovascular implantable electronic devices (CIEDs) are increasingly common in intensive care unit (ICU) patients.
  • Physicians face complex clinical, ethical, and legal challenges regarding CIEDs in end-of-life care.
  • Therapeutic goals often shift in patients with prolonged illness trajectories.

Purpose:

  • To highlight the critical need for ICU physicians to be aware of the implications of CIEDs in end-of-life care.
  • To address the ethical and legal complexities associated with CIED deactivation.
  • To emphasize the importance of patient consent and legal awareness in deactivation decisions.

Summary:

  • Deactivation of CIEDs, including pacemakers and implantable cardioverter-defibrillators (ICDs), presents significant ethical and legal considerations for ICU physicians.
  • While ethical permissibility for ICD deactivation in dying patients is generally agreed upon, patient consent is mandatory.
  • Practices and attitudes towards pacemaker versus ICD deactivation vary, necessitating awareness of specific device types and legal frameworks.

Impact:

  • Informed decision-making regarding CIED deactivation can improve end-of-life care for patients and provide support for physicians.
  • Promoting transparency and ethical/legal guidance is crucial for navigating these difficult decisions.
  • Ensuring patient autonomy and respecting individual wishes are paramount in managing CIEDs during terminal illness.